PMS24 THE COST EFFECTIVENESS OF STRONTIUM RANELATE VERSUS RISEDRONATE, RALOXIFENE, IBANDRONATE, ALENDRONATE AND CALCITONIN IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN IN TURKEY
May 1, 2011, 00:00
10.1016/j.jval.2011.02.709
https://www.valueinhealthjournal.com/article/S1098-3015(11)00848-5/fulltext
Title :
PMS24 THE COST EFFECTIVENESS OF STRONTIUM RANELATE VERSUS RISEDRONATE, RALOXIFENE, IBANDRONATE, ALENDRONATE AND CALCITONIN IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN IN TURKEY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00848-5&doi=10.1016/j.jval.2011.02.709
First page :
A127
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
167